The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Clinical Features of Varicella-Zoster Virus Infection
Open accessAbstract
Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia. Decades later, the virus may reactivate either spontaneously or after a number of triggering factors to cause herpes zoster (shingles). Varicella and its complications are more severe in the immunosuppressed. The most frequent and important complication of VZV reactivation is postherpetic neuralgia, the cause of which is unknown and for which treatment is usually ineffective. Reactivation of VZV may also cause a wide variety of neurological syndromes, the most significant of which is a vasculitis, which is treated with corticosteroids and the antiviral drug acyclovir. Other VZV reactivation complications include an encephalitis, segmental motor weakness and myelopathy, cranial neuropathies, Guillain–Barré syndrome, enteric features, and zoster sine herpete, in which the viral reactivation occurs in the absence of the characteristic dermatomally distributed vesicular rash of herpes zoster. There has also been a recent association of VZV with giant cell arteritis and this interesting finding needs further corroboration. Vaccination is now available for the prevention of both varicella in children and herpes zoster in older individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citationEfficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Self-citationRecommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITAL
Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T., & Isomura, S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90144-5 · Cited by 736
Immune Responses to Varicella-Zoster in the Aged
Burke, B. L. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340150091017 · Cited by 295
Stress-induced subclinical reactivation of varicella zoster virus in astronauts
Mehta, S. K., Cohrs, R. J., Forghani, B., Zerbe, G., Gilden, D. H., & Pierson, D. L. (2004) · Journal of Medical Virology · doi:10.1002/jmv.10555 · Cited by 275
Live attenuated varicella vaccine. Efficacy for children with leukemia in remission
Gershon, A. A. (1984) · JAMA · doi:10.1001/jama.252.3.355 · Cited by 197
Self-citationZoster sine herpete, A clinical variant
Gilden, D. H., Wright, R. R., Schneck, S. A., Gwaltney, J. M., & Mahalingam, R. (1994) · Annals of Neurology · doi:10.1002/ana.410350505 · Cited by 187
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts
Cohrs, R. J., Mehta, S. K., Schmid, D. S., Gilden, D. H., & Pierson, D. L. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21173 · Cited by 187
Latent varicella–zoster virus is located predominantly in neurons in human trigeminal ganglia
Kennedy, P. G. E., Grinfeld, E., & Gow, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4658 · Cited by 176
Self-citationCohrs, R. J., Barbour, M., & Gilden, D. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2789-2796.1996 · Cited by 170
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation
Kennedy, P. G. E., Rovnak, J., Badani, H., & Cohrs, R. J. (2015) · Journal of General Virology · doi:10.1099/vir.0.000128 · Cited by 159
Self-citationVaricella-Zoster Virus Gene Expression in Latently Infected and Explanted Human Ganglia
Kennedy, P. G. E., Grinfeld, E., & Bell, J. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11893-11898.2000 · Cited by 155
Self-citationLive Attenuated Varicella Vaccine
Gershon, A. A. (1984) · JAMA · doi:10.1001/jama.1984.03350030023016 · Cited by 153
Self-citationDeclining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years
Tseng, H. F., Harpaz, R., Luo, Y., Hales, C. M., Sy, L. S., Tartof, S. Y., Bialek, S. R., Hechter, R. C., & Jacobsen, S. J. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw047 · Cited by 152
A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61
Depledge, D. P., Ouwendijk, W. J. D., Sadaoka, T., Braspenning, S. E., Mori, Y., Cohrs, R. J., Verjans, G. M. G. M., & Breuer, J. (2018) · Nature Communications · doi:10.1038/s41467-018-03569-2 · Cited by 124
Update on Varicella Zoster Virus Vasculopathy
Nagel, M. A., & Gilden, D. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0407-z · Cited by 120
Varicella-Zoster Virus Gene 66 Transcription and Translation in Latently Infected Human Ganglia
Cohrs, R. J., Gilden, D. H., Kinchington, P. R., Grinfeld, E., & Kennedy, P. G. E. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6660-6665.2003 · Cited by 119
Self-citationVaricella‐zoster virus latency in human ganglia
Kennedy, P. G. E. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.362 · Cited by 115
Self-citationNagel, M. A., White, T., Khmeleva, N., Rempel, A., Boyer, P. J., Bennett, J. L., Haller, A., Lear-Kaul, K. C., Kandasmy, B., Amato, M. M., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2101 · Cited by 115
Herpes zoster vaccine live: A 10 year review of post-marketing safety experience
Willis, E. D., Woodward, M., Brown, E., Popmihajlov, Z., Saddier, P., Annunziato, P. W., Halsey, N. A., & Gershon, A. A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.11.013 · Cited by 112
Self-citationLatent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus
Chen, J. J., Gershon, A. A., Li, Z. S., Lungu, O., & Gershon, M. D. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10325 · Cited by 93
Self-citationImmune Responses to Varicella-Zoster in the Aged
Burke, B. L., Steele, R. W., Beard, O. W., Wood, J. S., Cain, T. D., & Marmer, D. J. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340150091016 · Cited by 91
Gershon, A. A., Chen, J. C., Davis, L. E., Krinsky, C., Cowles, R. A., Reichard, R. R., & Gershon, M. D. (2012) · PubMed Central · Cited by 77
Self-citationThe protean neurologic manifestations of varicella-zoster virus infection.
Nagel, M. A., & Gilden, D. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.7.489 · Cited by 74
VZV vasculopathy and postherpetic neuralgia
Gilden, D. H., Cohrs, R. J., & Mahalingam, R. (2005) · Neurology · doi:10.1212/01.wnl.0000148484.19070.4d · Cited by 69
Gershon, A. A. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30188-3 · Cited by 66
Self-citationVaricella-Zoster Virus Transcriptome in Latently Infected Human Ganglia
Nagel, M. A., Choe, A., Traktinskiy, I., Cordery-Cotter, R., Gilden, D., & Cohrs, R. J. (2010) · Journal of Virology · doi:10.1128/jvi.01862-10 · Cited by 63
Varicella-Zoster Virus and the Enteric Nervous System
Gershon, M. D., & Gershon, A. A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy407 · Cited by 61
Self-citationUse of Saliva to Identify Varicella Zoster Virus Infection of the Gut
Gershon, A. A., Chen, J. C., & Gershon, M. D. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ320 · Cited by 58
Self-citationQuan, D., Hammack, B. N., Kittelson, J. K., & Gilden, D. H. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.noc60049 · Cited by 52
(2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00012-2 · Cited by 51
Kennedy, P. G. E. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0430-x · Cited by 49
Self-citationPisapia, D. J., & Lavi, E. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.12.007 · Cited by 37
Varicella Virus Vaccination in the United States
Shaw, J., & Gershon, A. A. (2017) · Viral Immunology · doi:10.1089/vim.2017.0136 · Cited by 22
Self-citation
Cited by
Rafati, A., Pasebani, Y., Jameie, M., Yang, Y., Jameie, M., Ilkhani, S., Amanollahi, M., Sakhaei, D., Rahimlou, M., & Kheradmand, A. (2023) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2023.0160 · Cited by 45
Metadata
- Authors
- Kennedy, P. G. E., & Gershon, A. A.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2018-11-02
- Volume
- 10
- Issue
- 11
- Pages
- 609
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2899971178
- Cited by
- 369
- References
- 38
- FWCI
- 18.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.